Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Toshiaki Komori"'
Autor:
Satoshi Hamada, Yutaka Ito, Toyohiro Hirai, Kimihiko Murase, Takahiro Tsuji, Kohei Fujita, Tadashi Mio, Koichi Maekawa, Takashi Fujii, Shigeki Ono, Takashi Nishimura, Akihiko Hayashi, Toshiaki Komori, Naohisa Fujita, Akio Niimi, Satoshi Ichiyama, Kazuo Chin, Michiaki Mishima
Publikováno v:
International Journal of Mycobacteriology, Vol 5, Iss 2, Pp 170-176 (2016)
Objective/background: The prevalence of pulmonary nontuberculous mycobacterial (pNTM) disease, including Mycobacterium avium complex (MAC), varies widely according to geographic region. However, the factors that influence regional variations in pNTM
Externí odkaz:
https://doaj.org/article/9c192ec7a69042a7bcf9282acbc19686
Autor:
Masaki Nakanishi, Toshiaki Komori, Takeshi Kimura, Satoko Kurahashi, Mai Kodama, Towa Yasumoto, Naohisa Fujita, Yoko Tanino, Yukiji Yamada, Tomoko Iehara, Yuri Hirose, Noriko Kyotani, Yumiko Fujitomo
Publikováno v:
Kansenshogaku Zasshi. 92:855-862
Autor:
Shinji Yokoyama, Toshiaki Komori, Naohisa Fujita, Masakazu Nakamura, Takashi Miida, Masaji Ushiyama, Yoshihiro Miyamoto, Shizuya Yamashita, Kunihiro Nishimura, Satoshi Hirayama, Tamio Teramoto, Daisaku Masuda
Publikováno v:
Journal of Atherosclerosis and Thrombosis
Aim Most epidemiological and clinical studies calculated low-density lipoprotein-cholesterol (LDL-C) by Friedewald's formula which cannot be used in the postprandial samples. Although the homogeneous assays with poor analytical performance were withd
Autor:
Masaki Yamamoto, Shunji Takakura, Akihiko Hayashi, Yasufumi Matsumura, Harumi Watanabe, Toshiaki Komori, Tsunehiro Shimizu, Shoichi Doi, Naohisa Fujita, Michio Tanaka, Satoshi Ichiyama, Miki Nagao
Publikováno v:
Antimicrobial Agents and Chemotherapy. 59:5107-5113
The efficacy of cefmetazole and flomoxef (CF) for the treatment of patients with extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) bacteremia (ESBL-CF group) was compared with that of carbapenem treatment for ESBL-EC patients (ESBL-
Autor:
Hidetoshi Kumano, Masato Imai, Masakatsu Sunagawa, Daisuke Kanke, Toshiaki Komori, Kazuhiro Aoki, Masanobu Tanaka
Publikováno v:
Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons). 40:699-704
Autor:
Tomoyuki Yunoki, Yasufumi Matsumura, Masaki Yamamoto, Michio Tanaka, Kyoko Hamano, Satoshi Nakano, Taro Noguchi, Miki Nagao, Satoshi Ichiyama, Naohisa Fujita, Toshiaki Komori, Yukiji Yamada, Tsunehiro Shimizu, Akihiko Hayashi, Tamotsu Ono, Osamu Fukuda, Harumi Watanabe, Takeshi Higuchi, Shunji Takakura, Kunihiko Moro, Tomomi Hasegawa, Takashi Yoshida, Masayo Shigeta, Hiromi Terada, Chiyoko Fukumoto, Yoshie Mitamura, Fusayuki Tsuboi
Publikováno v:
Anaerobe. 48
This prospective multicenter surveillance study was designed to provide antimicrobial susceptibility profiles of clinical anaerobic bacteria with genetic species identification in Japan. In 2014, a total of 526 non-duplicate clinical anaerobic isolat
Autor:
Yoko, Tanino, Mai, Kodama, Hiroomi, Daicho, Yoshito, Miyauchi, Towa, Yasumoto, Yukiji, Yamada, Noriko, Kyotani, Satoko, Kurahashi, Masaji, Ushiyama, Takeshi, Kimura, Toshiaki, Komori, Yumiko, Fujitomo, Masaki, Nakanishi, Naohisa, Fujita
Publikováno v:
Rinsho Biseibutsu Jinsoku Shindan Kenkyukai shi = JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology. 27(1)
The 2-step method is an algorithm to detect toxigenic
Autor:
Aki Matsushima, Toshiaki Komori, S. Takakura, Naohisa Fujita, Tetsuya Yagi, Miki Nagao, Yasufumi Matsumura, Masaki Yamamoto, Satoshi Ichiyama, Mitsutaka Iguchi
Publikováno v:
Clinical Microbiology and Infection. 19(2):161-168
Plasmid-mediated AmpC β-lactamase-producing Escherichia coli (AmpC-E) bacteraemia was characterized by comparison with bacteraemia caused by extended-spectrum β-lactamase (ESBL)-producing E. coli (ESBL-E) and non-resistant E. coli (NR-E) in the era
Autor:
Kazuho Shimura, Toshiaki Komori, Yuko Kanbayashi, Chihiro Shimazaki, Kayo Ikeda, Yosuke Matsumoto, Kenichi Nomura, Masafumi Taniwaki, Kyoko Taniguchi, Naohisa Fujita, Kazuro Ikawa, Norifumi Morikawa, Yoshiko Fujimoto, Daisuke Shimizu
Publikováno v:
Journal of Antimicrobial Chemotherapy. 61:892-900
Objectives To establish a cefozopran (a fourth-generation cephem) population pharmacokinetic model using patient data and use it to explore alternative dosage regimens that could optimize the currently used dosing regimen to achieve higher likelihood
Autor:
Katsuko Okuzumi, Toshiaki Komori, Tomonari Yamashita, Mieko Goto, Takashi Takahashi, Shigeki Misawa
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 81:39-44
To determine the status of biosafety in clinical laboratories in Japan, we conducted a survey using questionnaires on the biosafety of laboratory personnel in 2004. We obtained data from 431 hospitals (response: 59.5%). Respondents were 301 instituti